Detalhe da pesquisa
1.
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
Eur Heart J
; 38(4): 292-301, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182242
2.
Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
PLoS One
; 10(7): e0134274, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218529
3.
Heme Oxygenase-1 Gene Therapy Provides Cardioprotection Via Control of Post-Ischemic Inflammation: An Experimental Study in a Pre-Clinical Pig Model.
J Am Coll Cardiol
; 66(2): 154-65, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160631
4.
Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis.
Exp Neurol
; 247: 259-66, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688679
5.
Neurofascin as a target for autoantibodies in peripheral neuropathies.
Neurology
; 79(23): 2241-8, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100406
6.
Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
PLoS One
; 10(8): e0137443, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317434